Literature DB >> 1513860

Cocaine euphoria, dysphoria, and tolerance assessed using drug-induced changes in brain-stimulation reward.

R A Frank1, P Z Manderscheid, S Panicker, H P Williams, D Kokoris.   

Abstract

The time course of cocaine-induced changes in self-stimulation thresholds were used to evaluate cocaine euphoria and dysphoria as a function of the chronicity of drug treatment, dosage level, and the spacing of injections. It was assumed that cocaine-induced decreases in thresholds were indicative of cocaine euphoria, while increases in thresholds reflected rebound dysphoric responses to cocaine administration. Three experiments were performed using self-stimulating rats implanted with ventral tegmental area electrodes. Cocaine's threshold-lowering effects were evident 15 min postinjection (IP) with thresholds returning to baseline by approximately 3.0 h after treatment. Little evidence for cocaine-induced increases in thresholds was observed during periods of chronic cocaine treatment. However, thresholds were slightly elevated upon withdrawal from chronic cocaine treatment in Experiments 2 and 3. No evidence of tolerance or sensitization to cocaine-induced shifts in thresholds was noted with single daily injections, while multiple daily injections produced tolerance to cocaine's threshold-lowering effects. It is concluded that cocaine's ability to enhance brain-stimulation reward is highly reliable and robust, while decreases in brain-stimulation reward associated with chronic cocaine treatment are less reliable and difficult to demonstrate. The possible influence of drug dosage on the induction of cocaine dysphoria and the ability of various self-stimulation procedures to measure dysphoric effects are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513860     DOI: 10.1016/0091-3057(92)90028-e

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Dopaminergic modulation of incentive motivation in adolescence: age-related changes in signaling, individual differences, and implications for the development of self-regulation.

Authors:  Monica Luciana; Dustin Wahlstrom; James N Porter; Paul F Collins
Journal:  Dev Psychol       Date:  2012-03-05

Review 2.  Recognition and treatment of dysthymia in elderly patients.

Authors:  S Bellino; F Bogetto; P Vaschetto; S Ziero; L Ravizza
Journal:  Drugs Aging       Date:  2000-02       Impact factor: 3.923

3.  Tolerance-like attenuation to contingent and noncontingent cocaine-induced elevation of extracellular dopamine in the ventral striatum following 7 days of withdrawal from chronic treatment.

Authors:  W M Meil; J M Roll; J W Grimm; A M Lynch; R E See
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

4.  Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds.

Authors:  R A Wise; E Munn
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

5.  Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.

Authors:  Athina Markou; Paul J Kenny
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 6.  Animal models and treatments for addiction and depression co-morbidity.

Authors:  Neil E Paterson; Athina Markou
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

7.  Cocaine tolerance in honey bees.

Authors:  Eirik Søvik; Jennifer L Cornish; Andrew B Barron
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Toxic cocaine- and convulsant-induced modification of forced swimming behaviors and their interaction with ethanol: comparison with immobilization stress.

Authors:  Tamaki Hayase; Yoshiko Yamamoto; Keiichi Yamamoto
Journal:  BMC Pharmacol       Date:  2002-11-09

9.  Alcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies.

Authors:  Yusuf S Althobaiti; Youssef Sari
Journal:  J Addict Res Ther       Date:  2016-06-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.